UK

GSK faces strike threat in UK, again, after workers pan pay raise
GSK faces strike threat in UK, again, after workers pan pay raise
Fierce Pharma
GSK
UK
strike
Flag link:
GSK told to pay higher royalties to AZ on Zejula sales
GSK told to pay higher royalties to AZ on Zejula sales
Pharmaphorum
GSK
AstraZeneca
ovarian cancer
Zejula
legal
UK
Flag link:
AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE
AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE
Fierce Pharma
AstraZeneca
Amgen
Tezspire
UK
NICE
asthma
severe asthma
Flag link:
‘Huge boost for biotech companies’: UK life sciences industry welcomes new enhanced R&D tax relief rate
‘Huge boost for biotech companies’: UK life sciences industry welcomes new enhanced R&D tax relief rate
Biopharma Reporter
biotech
UK
innovation
R&D
Flag link:
Novartis pulls the plug on UK-based cardiovascular study
Novartis pulls the plug on UK-based cardiovascular study
Endpoints
Novartis
clinical trials
Leqvio
UK
Cardiovascular
Flag link:
Moderna selects Oxfordshire as location for U.K.-based mRNA manufacturing facility
Moderna selects Oxfordshire as location for U.K.-based mRNA manufacturing facility
Medical Marketing and Media
Moderna Therapeutics
MRNA
UK
drug manufacturing
Flag link:
UK could allow reciprocal drug approvals with US FDA as soon as 2024
UK could allow reciprocal drug approvals with US FDA as soon as 2024
Endpoints
regulatory
drug approvals
FDA
UK
Flag link:
Novo Nordisk apologizes for not disclosing sponsorship of anti-obesity training
Novo Nordisk apologizes for not disclosing sponsorship of anti-obesity training
Financial Times
Novo Nordisk
obesity
UK
Saxenda
Flag link:
Jazz wins reimbursement nod from NICE for cannabinoid med Epidyolex
Jazz wins reimbursement nod from NICE for cannabinoid med Epidyolex
Fierce Pharma
Jazz Pharmaceuticals
Epidyolex
UK
NICE
cannabinoids
Flag link:
After years of back-and-forth, Gilead's CAR-T Yescarta sways England's cost watchdog NICE
After years of back-and-forth, Gilead's CAR-T Yescarta sways England's cost watchdog NICE
Fierce Pharma
Gilead Sciences
CAR-T
Yescarta
UK
NICE
Kite Pharma
Novartis
blood cancer
Flag link:
Construction on Merck's London research hub set to begin in April 2023
Construction on Merck's London research hub set to begin in April 2023
Endpoints
Merck
London
R&D
UK
Flag link:
Axcella Clears Regulatory Path for Long COVID Therapeutic
Axcella Clears Regulatory Path for Long COVID Therapeutic
BioSpace
Axcella Therapeutics
Long COVID
COVID-19
AXA1125
UK
Flag link:
AbbVie and Lilly have sent a warning signal to the UK government by leaving the voluntary medicines pricing agreement in protest over increasingly punitive revenue clawbacks
AbbVie and Lilly have sent a warning signal to the UK government by leaving the voluntary medicines pricing agreement in protest over increasingly punitive revenue clawbacks
ABPI
AbbVie
Eli Lilly
UK
NHS
drug pricing
Flag link:
UK signs deal with BioNTech for cutting-edge cancer trials
UK signs deal with BioNTech for cutting-edge cancer trials
Financial Times
BioNTech
UK
cancer
oncology
clinical trials
Flag link:
Moderna finalizes decade-long mRNA alliance with U.K.
Moderna finalizes decade-long mRNA alliance with U.K.
Medical Marketing and Media
Moderna Therapeutics
UK
vaccines
MRNA
Flag link:
GSK embraces hybrid work for the long haul at new London HQ
GSK embraces hybrid work for the long haul at new London HQ
Fierce Pharma
GSK
London
UK
hybrid work
remote work
Flag link:
GSK picks downtown London for new corporate headquarters
GSK picks downtown London for new corporate headquarters
WRAL Techwire
GSK
London
UK
headquarters
Flag link:
Britain's health regulator backs COVID vaccine for infants from six months
Britain's health regulator backs COVID vaccine for infants from six months
Yahoo/Reuters
UK
COVID-19
vaccines
infants
pediatric
Pfizer
BioNTech
Flag link:
UK regulators warn of ocular side effects after treatment with Sanofi's Dupixent
UK regulators warn of ocular side effects after treatment with Sanofi's Dupixent
Fierce Pharma
Regeneron
Sanofi
Dupixent
UK
side effects
Flag link:
Pfizer CEO Bourla stung by UK's pharma marketing regulator over kids' COVID vax claims: report
Pfizer CEO Bourla stung by UK's pharma marketing regulator over kids' COVID vax claims: report
Fierce Pharma
Pfizer
COVID-19
vaccines
UK
Albert Bourla
Pharma CEOs
pharma marketing
regulatory
PMCPA
Flag link:

Pages